Form 8-K - Current report:
SEC Accession No. 0001104659-21-148281
Filing Date
2021-12-10
Accepted
2021-12-09 20:08:10
Documents
14
Period of Report
2021-12-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2135090d1_8k.htm   iXBRL 8-K 32141
2 EXHIBIT 99.1 tm2135090d1_ex99-1.htm EX-99.1 14348
6 GRAPHIC tm2135090d1_ex99-1img001.jpg GRAPHIC 5269
  Complete submission text file 0001104659-21-148281.txt   232001

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bpmc-20211208.xsd EX-101.SCH 3055
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bpmc-20211208_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bpmc-20211208_pre.xml EX-101.PRE 22379
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2135090d1_8k_htm.xml XML 3493
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 211483330
SIC: 2834 Pharmaceutical Preparations